The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S. (2005) · Clinical Infectious Diseases · doi:10.1086/432803 · Cited by 1,404
Chastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376
Tenover, F. C., Arbeit, R. D., Goering, R. V., & Molecular Typing Working Group of the Society for Healthcare Epidemiology of America (1997) · Infection Control & Hospital Epidemiology · doi:10.1086/647644 · Cited by 588
Fridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
Go, E. S., Urban, C., Burns, J., Mariano, N., Mosinka-Snipas, K., Rahal, J. J., Kreiswirth, B., & Eisner, W. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90694-7 · Cited by 369
Corbella, X., Montero, A., Pujol, M., Domínguez, M. A., Ayats, J., Argerich, M. J., Garrigosa, F., Ariza, J., & Gudiol, F. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.11.4086-4095.2000 · Cited by 348
Slaughter, S., Hayden, M. K., Nathan, C., Hu, T.-C., Rice, T., Van Voorhis, J., Matushek, M., Franklin, C., & Weinstein, R. A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-6-199609150-00004 · Cited by 311
Manikal, V. M., Landman, D., Saurina, G., Oydna, E., Lal, H., & Quale, J. (2000) · Clinical Infectious Diseases · doi:10.1086/313902 · Cited by 309
Landman, D., Quale, J. M., Mayorga, D., Adedeji, A., Vangala, K., Ravishankar, J., Flores, C., & Brooks, S. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.13.1515 · Cited by 301
Multidrug-Resistant Acinetobacter baumannii
Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y., & Carmeli, Y. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040001 · Cited by 285
Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings
Garnacho-Montero, J., Ortiz-Leyba, C., Fernández-Hinojosa, E., Aldabó-Pallás, T., Cayuela, A., Marquez-Vácaro, J. A., Garcia-Curiel, A., & Jiménez-Jiménez, F. J. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2598-0 · Cited by 276
Controlling Antimicrobial Resistance in Hospitals: Infection Control and Use of Antibiotics
Weinstein, R. A. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010206 · Cited by 275
De-escalation therapy in ventilator-associated pneumonia*
Rello, J., Vidaur, L., Sandiumenge, A., Rodríguez, A., Gualis, B., Boque, C., & Diaz, E. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145997.10438.28 · Cited by 249
Climo, M. W., Israel, D. S., Wong, E. S., Williams, D., Coudron, P., & Markowitz, S. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_1-199806150-00005 · Cited by 247
Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting
Navon-Venezia, S., Ben-Ami, R., & Carmeli, Y. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000171920.44809.f0 · Cited by 242
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria
Falagas, M. E., Bliziotis, I. A., Kasiakou, S. K., Samonis, G., Athanassopoulou, P., & Michalopoulos, A. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-24 · Cited by 224
Self-citationSimor, A. E., Lee, M., Vearncombe, M., Jones-Paul, L., Barry, C., Gomez, M., Fish, J. S., Cartotto, R. C., Palmer, R., & Louie, M. (2002) · Infection Control & Hospital Epidemiology · doi:10.1086/502046 · Cited by 198
Epidemiology and Clinical Outcomes of Patients with Multiresistant Pseudomonas aeruginosa
Harris, A., Torres‐Viera, C., Venkataraman, L., DeGirolami, P., Samore, M., & Carmeli, Y. (1999) · Clinical Infectious Diseases · doi:10.1086/514760 · Cited by 194
EPIDEMIC BACTEREMIA DUE TO ACINETOBACTER BAUMANNII IN FIVE INTENSIVE CARE UNITS
Beck‐Sagué, C. M., Jarvis, W. R., BROOK, J. H., et al. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115714 · Cited by 185
Risk Factors for Imipenem-Resistant Pseudomonas aeruginosa among Hospitalized Patients
Harris, A. D., Smith, D., Johnson, J. A., Bradham, D. D., & Roghmann, M.-C. (2002) · Clinical Infectious Diseases · doi:10.1086/338237 · Cited by 185
Paramythiotou, E., Lucet, J., Timsit, J., Vanjak, D., Paugam‐Burtz, C., Trouillet, J., Belloc, S., Kassis, N., Karabinis, A., & Andremont, A. (2004) · Clinical Infectious Diseases · doi:10.1086/381550 · Cited by 177
Trouillet, J. L., Vuagnat, A., Combes, A., Kassis, N., Chastre, J., & Gibert, C. (2002) · Clinical Infectious Diseases · doi:10.1086/339488 · Cited by 176
Gaynes, R. P., & Edwards, J. R. (2005) · Cited by 176
Risk Factors for Acquisition of Imipenem-Resistant Acinetobacter baumannii : a Case-Control Study
Lee, S.-O., Kim, N. J., Choi, S.-H., Kim, T. H., Chung, J.-W., Woo, J.-H., Ryu, J., & Kim, Y. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.224-228.2004 · Cited by 175
Richard, P., Floch, R. L., Chamoux, C., Pannier, M., Espaze, E., & Richt, H. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.2.377 · Cited by 172
Harris, A. D., Samore, M. H., Lipsitch, M., Kaye, K. S., Perencevich, E., & Carmeli, Y. (2002) · Clinical Infectious Diseases · doi:10.1086/340533 · Cited by 171
Hsueh, P.-R., Chen, M.-L., Sun, C.-C., Chen, W.-H., Pan, H.-J., Yang, L.-S., Chang, S.-C., Ho, S.-W., Lee, C.-Y., Hsieh, W.-C., et al. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0801.000454 · Cited by 162
Crespo, M., Woodford, N., Sinclair, A., Kaufmann, M. E., Turton, J. F., Glover, J., Vélez, J. D., Castañeda-Ramirez, C. R., Recalde, M. P., & Livermore, D. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5094-5101.2004 · Cited by 153
Struelens, M. J., Carlier, E., Maes, N., Serruys, E., Quint, W. G. V., & van Belkum, A. (1993) · Journal of Hospital Infection · doi:10.1016/0195-6701(93)90005-k · Cited by 151
Wang, S. H., Sheng, W., Chang, Y.-Y., et al. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1348 · Cited by 149
Shafie, S. S. E., Alishaq, M., & Garcia, M. L. (2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.09.024 · Cited by 147
The need for new therapeutic agents: what is in the pipeline?
SHAH, P. M. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01141.x · Cited by 147
Molecular Characterization of an Epidemic Clone of Panantibiotic-ResistantPseudomonas aeruginosa
Deplano, A., Denis, O., Poirel, L., Hocquet, D., Nonhoff, C., Byl, B., Nordmann, P., Vincent, J., & Struelens, M. J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.3.1198-1204.2005 · Cited by 146
Cao, B., Wang, H., Sun, H., Zhu, Y., & Chen, M. (2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.03.021 · Cited by 143
Baraibar, J., Correa, H., Mariscal, D., Gallego, M., Vallés, J., & Rello, J. (1997) · CHEST Journal · doi:10.1378/chest.112.4.1050 · Cited by 135
Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection
Defez, C., Fabbro-Péray, P., Bouziges, N., Gouby, A., Mahamat, A., Daurès, J., & Sotto, A. (2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.03.022 · Cited by 132
Flamm, R. K., Weaver, M. K., Thornsberry, C., Jones, M. E., Karlowsky, J. A., & Sahm, D. F. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2431-2436.2004 · Cited by 122
Nseir, S., Pompéo, C. D., Soubrier, S., Delour, P., Lenci, H., Roussel‐Delvallez, M., Onimus, T., Saulnier, F., Mathieu, D., & Durocher, A. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000152230.53473.a1 · Cited by 118
Maragakis, L. L. (2004) · JAMA · doi:10.1001/jama.292.24.3006 · Cited by 109
Risk factors for infections with multidrug‐resistant Pseudomonas aeruginosa in patients with cancer
Ohmagari, N., Hanna, H. A., Graviss, L. S., Hackett, B. C., Perego, C., González, V., Dvorak, T. L., Hogan, H., Hachem, R. Y., Rolston, K. V., et al. (2005) · Cancer · doi:10.1002/cncr.21115 · Cited by 107
Srinivasan, A., Song, X., Ross, T. L., Merz, W. G., Brower, R. G., & Perl, T. M. (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502079 · Cited by 107
Berrouane, Y., McNutt, L., Buschelman, B. J., Rhomberg, P. R., Sanford, M. D., Hollis, R. J., Pfaller, M. A., & Herwaldt, L. A. (2000) · Clinical Infectious Diseases · doi:10.1086/317501 · Cited by 102
Harris, A. D., Perencevich, E. N., Roghmann, M., MORRIS, G. L., Kaye, K. S., & Johnson, J. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.854-858.2002 · Cited by 102
Kolmos, H. J., Thuesen, B., Nielsen, S. V., Lohmann, M., Kristoffersen, K., & Rosdahl, V. T. (1993) · Journal of Hospital Infection · doi:10.1016/0195-6701(93)90085-e · Cited by 89
Hsu, D. I., Okamoto, M. P., Murthy, R. K., & Wong‐Beringer, A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki026 · Cited by 87
Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy
Plummer, S. F., Garaiova, I., Sarvotham, T., Cottrell, S. L., Le Scouiller, S., Weaver, M. A., Tang, J., Dee, P., & Hunter, J. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.04.004 · Cited by 84
Zavascki, A. P., Cruz, R. P., & Goldani, L. Z. (2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.09.007 · Cited by 84
Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit — an infection control study
Douglas, M. W., Mulholland, K., Denyer, V., & Gottlieb, T. (2001) · Burns · doi:10.1016/s0305-4179(00)00084-x · Cited by 83
Stone, J. W., & Das, B. C. (1986) · Journal of Hospital Infection · doi:10.1016/0195-6701(86)90025-3 · Cited by 74
Endemic Multidrug-Resistant Pseudomonas aeruginosa in Critically Ill Patients
Ortega, B., Groeneveld, A. B. J., & Schultsz, C. (2004) · Infection Control · doi:10.1086/502303 · Cited by 64
Kuo, L.-C., Teng, L., Yu, C., Ho, S., & Hsueh, P. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1759-1763.2004 · Cited by 60
Garland, S. M., Mackay, S., Tabrizi, S. N., et al. (1996) · Journal of Hospital Infection · doi:10.1016/s0195-6701(96)90099-7 · Cited by 43
de Jonge, E. (2005) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000155352.01489.11 · Cited by 42
Jeena, P. M., Thompson, E., Nchabeleng, M., & Sturm, A. W. (2001) · Annals of Tropical Paediatrics · doi:10.1080/02724930120077835 · Cited by 38
Maslow, J. N., Glaze, T., Adams, P., & Lataillade, M. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502489 · Cited by 37
Efficacy and Tolerability of ClO2‐Generating Gloves
Barza, M. (2004) · Clinical Infectious Diseases · doi:10.1086/382535 · Cited by 32
Spanik, S., Novotný, J., Mateicka, F., et al. (1999) · Journal of Infection and Chemotherapy · doi:10.1007/s101560050031 · Cited by 28
A Pilot Study of Antibiotic Cycling in the Community Hospital Setting
Bruno‐Murtha, L. A., Brusch, J. L., Bor, D. H., Li, W., & Zucker, D. R. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502491 · Cited by 26
Epidemiology of Ciprofloxacin-Resistant Pseudomonas aeruginosa in a Veterans Affairs Hospital
Khayr, W. F., Rheault, W., Waiters, L., & Walters, A. W. (2000) · American Journal of Therapeutics · doi:10.1097/00045391-200007050-00007 · Cited by 9
Cited by
Dissemination and publication of research findings: an updated review of related biases
Song, F., Parekh, Hooper, L., Loke, Y., Ryder, J., Sutton, A., Hing, C., Kwok, C., Pang, C., & Harvey, I. (2010) · Health Technology Assessment · doi:10.3310/hta14080 · Cited by 1,039
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
Mesaros, N., Nordmann, P., Plésiat, P., Roussel-Delvallez, M., Van Eldere, J., Glupczynski, Y., Van Laethem, Y., Jacobs, F., Lebecque, P., Malfroot, A., et al. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01681.x · Cited by 585
Multidrug resistant Acinetobacter
Manchanda, V., Sanchaita, S., & Singh, N. (2010) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.68538 · Cited by 555
Crossman, L. C., Gould, V. C., Dow, J. M., Vernikos, G. S., Okazaki, A., Sebaihia, M., Saunders, D., Arrowsmith, C., Carver, T., Peters, N., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-4-r74 · Cited by 544
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
Karageorgopoulos, D. E., & Falagas, M. E. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70279-2 · Cited by 446
Self-citation
Metadata
- Authors
- Falagas, M. E., & Kopterides, P.
- Venue
- Journal of Hospital Infection
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 64
- Issue
- 1
- Pages
- 7-15
- ISSN
- 0195-6701 (ISSN-L)
- OpenAlex
- W2071236779
- Cited by
- 305
- References
- 60
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.